November 16, 2016 - By Nellie Frank · 0 Comments
The stock of Strata Skin Sciences Incorporated (NASDAQ:SSKN) registered a decrease of 3.92% in short interest. SSKN’s total short interest was 304,200 shares in November as published by FINRA. Its down 3.92% from 316,600 shares, reported previously. With 16,300 shares average volume, it will take short sellers 19 days to cover their SSKN’s short positions. The short interest to Strata Skin Sciences Incorporated’s float is 3.55%. About 40 shares traded hands. STRATA Skin Sciences Inc (NASDAQ:SSKN) has declined 46.24% since April 14, 2016 and is downtrending. It has underperformed by 50.92% the S&P500.
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The company has a market cap of $5.45 million. The Firm is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. It currently has negative earnings. The Firm has three divisions: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., incorporated on October 3, 1997, is a medical technology company. The Firm is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Firm has three divisions: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Firm has approximately two distribution channels for phototherapy treatment equipment. The Firm places its lasers in a physician’s office or sells its lasers through a distributor or directly to a physician.
More notable recent STRATA Skin Sciences Inc (NASDAQ:SSKN) news were published by: Streetinsider.com which released: “MELA Sciences (MELA) Will Change Name to ‘STRATA Skin Sciences, Inc.'” on December 22, 2015, also Globenewswire.com with their article: “STRATA Skin Sciences Names Frank McCaney as President and CEO” published on November 01, 2016, Seekingalpha.com published: “STRATA Skin Sciences’ (SSKN) CEO Frank McCaney on Q3 2016 Results – Earnings …” on November 11, 2016. More interesting news about STRATA Skin Sciences Inc (NASDAQ:SSKN) were released by: Globenewswire.com and their article: “STRATA Skin Sciences, Inc. Announces FDA Approval of PMA Supplemental for …” published on March 10, 2016 as well as Globenewswire.com‘s news article titled: “STRATA Skin Sciences to Host Key Opinion Leader Lunch” with publication date: June 13, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank